Concepedia

Deb Chatterjee

DC

12

Publications

608

Citations

11

H-Index

2002

Active since

Affiliations

University of Missouri–Kansas City(Current)

United States Food and Drug Administration

Material Measurement Laboratory

Center for Drug Evaluation and Research

Center for Devices and Radiological Health

Deb Chatterjee is an author at University of Missouri–Kansas City specializing in engineering, computational electromagnetics, and antenna.

ORCID

Top concepts

Publications per year

2002–2020

12

Publications

12

FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer

Shaily Arora, Sanjeeve Balasubramaniam, Hui Zhang et al. · The Oncologist · 2020 · 171 citations · Full text

FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer

Preeti Narayan, Tatiana M. Prowell, Jennifer Gao et al. · Clinical Cancer Research · 2020 · 157 citations · Full text

Characteristic Mode Analysis of a Class of Empirical Design Techniques for Probe-Fed, U-Slot Microstrip Patch Antennas

Mahrukh Khan, Deb Chatterjee · IEEE Transactions on Antennas and Propagation · 2016 · 111 citations

, , +7

Small-size wide-bandwidth microstrip patch antennas

Aaron K. Shackelford, K.F. Lee, Deb Chatterjee et al. · 2002 · 33 citations

, , +6

Plasmonic Nanoantenna Optimization Using Characteristic Mode Analysis

Sumitra Dey, Deb Chatterjee, Edward J. Garboczi et al. · IEEE Transactions on Antennas and Propagation · 2019 · 24 citations

, , +14

Rows per page

1–5 of 12